BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12824251)

  • 1. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Abatangelo G; Plebani M; Secchi AG
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3052-8. PubMed ID: 12824251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypsin inhibitory capacity in vernal keratoconjunctivitis.
    Ghavami S; Hashemi M; de Serres FJ; Bajestani SN; Mehrabifar H; Leonardi A
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):264-9. PubMed ID: 17197542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis.
    Kumagai N; Yamamoto K; Fukuda K; Nakamura Y; Fujitsu Y; Nuno Y; Nishida T
    J Allergy Clin Immunol; 2002 Sep; 110(3):489-91. PubMed ID: 12209100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
    Leonardi A; Sathe S; Bortolotti M; Beaton A; Sack R
    Allergy; 2009 May; 64(5):710-7. PubMed ID: 19220217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histaminase activity in patients with vernal keratoconjunctivitis.
    Abelson MB; Leonardi AA; Smith LM; Fregona IA; George MA; Secchi AG
    Ophthalmology; 1995 Dec; 102(12):1958-63. PubMed ID: 9098303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atopy and serum eosinophil cationic protein in 110 white children with vernal keratoconjunctivitis: differences between tarsal and limbal forms.
    Pucci N; Novembre E; Lombardi E; Cianferoni A; Bernardini R; Massai C; Caputo R; Campa L; Vierucci A
    Clin Exp Allergy; 2003 Mar; 33(3):325-30. PubMed ID: 12614446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil cationic protein in tears in allergic conjunctivitis.
    Montan PG; van Hage-Hamsten M
    Br J Ophthalmol; 1996 Jun; 80(6):556-60. PubMed ID: 8759270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tearfilm immunoglobulin E (IgE) level in vernal keratoconjunctivitis by ELISA.
    Pokharel S; Shah DN; Joshi SN; Choudhary M
    Kathmandu Univ Med J (KUMJ); 2009; 7(26):104-8. PubMed ID: 20071840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
    Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
    Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activated eosinophils in vernal keratoconjunctivitis].
    Saiga T; Shimizu Y
    Nihon Rinsho; 1993 Mar; 51(3):816-9. PubMed ID: 8492463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes.
    Symeonidis C; Papakonstantinou E; Galli A; Tsinopoulos I; Mataftsi A; Batzios S; Dimitrakos SA
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):741-9. PubMed ID: 23254483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear Martix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Post-Lasik Ectasia.
    Elmohamady MN; Abdelghaffar W; Salem TI
    Int Ophthalmol; 2019 Mar; 39(3):631-637. PubMed ID: 29478225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A; Borghesan F; Avarello A; Plebani M; Secchi AG
    Br J Ophthalmol; 1997 Jan; 81(1):23-6. PubMed ID: 9135403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.
    Sobrin L; Liu Z; Monroy DC; Solomon A; Selzer MG; Lokeshwar BL; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1703-9. PubMed ID: 10845589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear chymase in vernal keratoconjunctivitis.
    Ebihara N; Funaki T; Takai S; Miyazaki M; Fujiki K; Murakami A
    Curr Eye Res; 2004 Jun; 28(6):417-20. PubMed ID: 15512949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma levels of substance P in vernal keratoconjunctivitis.
    Lambiase A; Bonini S; Micera A; Tirassa P; Magrini L; Bonini S; Aloe L
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2161-4. PubMed ID: 9331280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases.
    Leonardi A; Borghesan F; Faggian D; Depaoli M; Secchi AG; Plebani M
    Am J Ophthalmol; 2000 Feb; 129(2):151-8. PubMed ID: 10682966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis.
    Leonardi A; Borghesan F; Faggian D; Secchi A; Plebani M
    Allergy; 1995 Jul; 50(7):610-3. PubMed ID: 8588697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of Fc epsilon receptor I-bindable immunoglobulin E in the tear fluid and increased immunoglobulin E-saturated cells in the giant papillae of vernal keratoconjunctivitis patients.
    Ebihara N; Okumura K; Nakayasu K; Kanai A; Ra C
    Jpn J Ophthalmol; 2002; 46(4):357-63. PubMed ID: 12225812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatinase B in vernal keratoconjunctivitis.
    Abu El-Asrar AM; Van Aelst I; Al-Mansouri S; Missotten L; Opdenakker G; Geboes K
    Arch Ophthalmol; 2001 Oct; 119(10):1505-11. PubMed ID: 11594952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.